Mizuho raised the firm’s price target on Tenet Healthcare to $110 from $100 and keeps a Buy rating on the shares. The analyst says the firm’s valuation takes into account the company’s net operating income.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on THC:
- Barclays starts health care facilities, managed care group with Neutral view
- Tenet Healthcare initiated with an Overweight at Barclays
- Tenet Healthcare Sells California Hospitals to Adventist Health
- Tenet Healthcare sells two hospitals, enters partnership with Adventist Heal
- Tenet Healthcare Announces Redemption of Senior Notes
